Westbourne Investment Advisors Inc. reduced its stake in shares of UnitedHealth Group Inc. (NYSE:UNH) by 21.8% during the second quarter, Holdings Channel reports. The firm owned 7,880 shares of the healthcare conglomerate’s stock after selling 2,200 shares during the period. Westbourne Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $1,113,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. MCF Advisors LLC raised its position in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares during the period. Parkside Financial Bank & Trust increased its stake in UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. Feltz Wealth PLAN Inc. purchased a new stake in UnitedHealth Group during the second quarter worth $143,000. Benjamin F. Edwards & Company Inc. increased its stake in UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares in the last quarter. Finally, Evanson Asset Management LLC purchased a new stake in UnitedHealth Group during the second quarter worth $201,000. Institutional investors and hedge funds own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) opened at 138.32 on Friday. The stock has a market cap of $131.73 billion, a P/E ratio of 21.65 and a beta of 0.57. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The firm’s 50-day moving average price is $138.51 and its 200 day moving average price is $135.81.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.07. The business had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. On average, equities analysts expect that UnitedHealth Group Inc. will post $7.92 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.81%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s payout ratio is currently 39.12%.
UNH has been the subject of several recent analyst reports. Wedbush reaffirmed an “outperform” rating and set a $165.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price target for the company in a research report on Friday, July 22nd. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Citigroup Inc. raised their price objective on UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a research note on Wednesday, July 20th. Finally, Credit Suisse Group AG restated a “buy” rating and set a $148.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, June 29th. One equities research analyst has rated the stock with a hold rating, twenty-four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.65% of the stock is owned by insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.